All Web Images Videos News
Settings
Appearance
Site Icons
Font Size
Font
General
Infinite Scroll
Open Links in a New Tab
Safe Search
New York hospital creates special-edition basketball to bounce sickle cell up the agenda
FiercePharma - Sep 09, 2024
What’s Next for Biotech? Join Fierce Biotech Editors in Boston at Fierce Biotech Summit
FierceBiotech - Aug 18, 2024
Amid contract manufacturing wind-down, Moderna advances production efforts for cancer programs
FiercePharma - Feb 21, 2024
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
FierceBiotech - Jan 13, 2022
Sanofi pays $125M to go after undruggable inflammatory target with Recludix's preclinical program
FierceBiotech - Jul 19, 2023
FDA looks to bypass cancer drugs' companion diagnostics with new pilot program: Pazdur
FierceBiotech - Nov 17, 2022
Pfizer sends 5 pipeline programs packing amid cost-savings overhaul
FierceBiotech - Oct 30, 2023
Halda raises $126M to advance 'hold and kill' solid tumor drugs into the clinic
FierceBiotech - Aug 11, 2024
Adaptimmune, Monte Rosa and Intellia discontinue programs
FierceBiotech - Nov 08, 2023
Top 10 pharma R&D budgets in 2022
FierceBiotech - Mar 26, 2023
More results